Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00237133

Completed

Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women (PREDICT)

Locally Advanced Breast Cancer
NCT00665899

Completed

A Couples Approach to Enhance Breast Cancer Survivorship (CanThrive)

Early-Stage Breast Cancer
NCT02140437

Withdrawn

Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC

Carcinoma Breast Stage IV
NCT01563588

Terminated

Support and Rehabilitation Protocol for Non Metastatic Breast Cancer Patients in Complete Remission After Chemotherapy

Non Metastatic Breast Cancer
NCT02161315

Unknown

Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer

Carcinoma Breast Stage IV
NCT00636441

Terminated

Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer

Early-Stage Breast Cancer
NCT00965939

Completed

An Observational Study to Assess Response to Tamoxifen in Breast Cancer Patients (CYPTAMBRUT-2)

ER-positive Breast Cancer
NCT01558258

Completed

A Mindfulness Meditation-Based Intervention for Younger Breast Cancer Survivors

Younger Breast Cancer Survivors
NCT01166581

Terminated

Impact of Breast Magnetic Resonance Imaging (MRI) on Mastectomy Rates

Early Stage Breast Cancer
NCT00233077

Completed

Patient Centered Randomized Controlled Trial

Early-Stage Breast Cancer
NCT00662025

Completed

Study Of Sunitinib With Capecitabine In Breast Cancer

Advanced/Metastatic Breast Cancer
NCT00669565

Completed

Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer

Carcinoma Breast Stage IV
NCT00433095

Completed

Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer

Carcinoma Breast Stage IV
NCT00191152

Completed

A Phase III Trial For Patients With Metastatic Breast Cancer

Breast Cancer | Breast Neoplasms | Cancer of the Breast
NCT00851110

Terminated

Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors

High-Risk Breast Cancer
NCT04693338

Completed

Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8
NCT03038152

Completed

Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery

Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Breast Carcinoma Metastatic in Lymph Node | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7
NCT06297265

Recruiting

Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery

Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Localized Breast Carcinoma
NCT01149083

Completed

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Unresectable Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma
NCT00684983

Completed

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

Recurrent Breast Carcinoma | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7
NCT07610720

Recruiting

Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer

HER2-Positive Metastatic Breast Cancer | Advanced/Metastatic Breast Cancer
NCT07570524

Not yet recruiting

Predicting Response to Immunochemotherapy in Early Triple Negative Breast Cancer (PRIME-TNBC)

Triple-negative Breast Cancer (TNBC)
NCT07507890

Recruiting

Endoscopic Nipple-Sparing Mastectomy Through a Single Axillary Incision in Breast Cancer (Mini-B)

Breast Cancer | Breast Cancer - Ductal Carcinoma in Situ (DCIS)
NCT07342283

Recruiting

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer

Triple Negative Breast Cancer (TNBC)
NCT07208149

Recruiting

A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)

Triple-Negative Breast Cancer (TNBC)
NCT07178171

Recruiting

A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC

TNBC, Triple Negative Breast Cancer
NCT07063667

Not yet recruiting

Artificial Intelligence Model-Assisted Accurate Diagnosis of Early-Stage Breast Cancer

Breast Cancer, Metastatic | Artifical Intelligence
NCT07047365

Recruiting

TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer

HER2-positive Advanced Breast Cancer
NCT06966050

Recruiting

Multi-center MRD Registry for Inflammatory Breast Cancer

Breast Cancer
NCT06773143

Recruiting

Effect of Subanesthetic Dose of Esketamine on Sleep Quality (EOSDOEOSQ)

Insomnia | Breast Cancer Surgery | Esketamine
NCT06682195

Recruiting

Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)

TNBC, Triple Negative Breast Cancer
NCT06556862

Not yet recruiting

Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor

HR+/HER2- Advanced Breast Cancer
NCT06551116

Recruiting

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer
NCT06099769

Recruiting

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT06050109

Recruiting

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Endocrine Therapy | Breast Cancer Female
NCT05883852

Recruiting

EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer

HER2 Positive Early Breast Cancer
NCT05856383

Recruiting

Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC (HER2-VIP)

HER2-positive Advanced Breast Cancer
NCT05398861

Recruiting

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

HER-2 Negative Breast Cancer
NCT04967976

Recruiting

Breast Mesh Used in Two-staged Breast Reconstruction

Breast Cancer | Breast Reconstruction | Radiation | Synthetic Mesh
NCT04767659

Recruiting

Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging

Chemotherapy Effect | Breast Cancer Female
NCT04644406

Not yet recruiting

PETRA: PErtuzumab and Trastuzumab Biosimilars Real Life Association for the First Line Treatment of HER2-positive Metastatic Breast Cancer, an Observational Prospective Multicenter Study (PETRA)

HER-2 Positive Breast Cancer
NCT04626986

Recruiting

Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor

Breast Tumor | Microwave Ablation | Breast Conserving Surgery
NCT04458532

Recruiting

Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer

Early Stage Breast Cancer
NCT03390894

Recruiting

Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

Invasive Breast Cancer Early Stages
NCT03616587

Active, not recruiting

Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer. (SERENA-1)

ER+ HER2- Advanced Breast Cancer
NCT07484776

Active, not recruiting

Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer

Triple-Negative Breast Cancer (TNBC)
NCT04494425

Active, not recruiting

Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer (DB-06)

Advanced or Metastatic Breast Cancer
NCT05113251

Active, not recruiting

Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer

Breast Cancer | Breast Neoplasms | HER2-positive Early Breast Cancer
NCT01984138

Active, not recruiting

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy (REVIVE)

Breast Cancer | Estrogen Receptor Positive Breast Cancer
NCT06961331

Completed

Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.

Metastatic HER2+ Advanced Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations